“Studying and Improving Treatment of Calprotectin, Helicobacter Pylori and Interleukin-6 in Blood of Patients with Covid-19”, Journal of Pharmaceutical Negative Results, pp. 2387–2393, Nov. 2022, doi: 10.47750/pnr.2022.13.S08.295.